Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glutamate ionotropic receptor AMPA type subunit 2 | 0.573 | 0.692 | 1.00 |
|
disease | 0.720 | moderate | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.720 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
disease | 0.700 | None | 0.962 | 5 | 0 | 1985 | 2020 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
disease | 0.700 | None | 0.952 | 5 | 0 | 1973 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.700 | None | 0.942 | 5 | 0 | 1996 | 2019 | ||||||||
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.930 | 4 | 0 | 1966 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.984 | 3 | 0 | 1996 | 2019 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.700 | None | 0.982 | 3 | 0 | 2000 | 2020 | ||||||||
|
interleukin 5 | 0.437 | 0.846 | 5.7E-03 |
|
disease | 0.700 | None | 0.973 | 3 | 0 | 1991 | 2020 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.700 | None | 0.982 | 3 | 0 | 1995 | 2020 | ||||||||
|
microtubule associated protein tau | 0.446 | 0.923 | 6.0E-03 |
|
disease | 0.700 | None | 0.990 | 3 | 0 | 1988 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.700 | None | 1.000 | 3 | 0 | 1999 | 2020 | ||||||||
|
hepcidin antimicrobial peptide | 0.433 | 0.846 | 8.2E-03 |
|
disease | 0.700 | None | 0.966 | 3 | 0 | 2002 | 2020 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.986 | 2 | 0 | 2000 | 2019 | ||||||||
|
calpain 10 | 0.621 | 0.577 | 6.9E-13 |
|
disease | 0.700 | None | 0.926 | 2 | 0 | 2000 | 2019 | ||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 0.700 | None | 1.000 | 2 | 0 | 1966 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 0.895 | 2 | 0 | 1992 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.946 | 2 | 0 | 1991 | 2020 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
phenotype | 0.700 | None | 1.000 | 2 | 0 | 1991 | 2019 | ||||||||
|
C-C motif chemokine ligand 11 | 0.473 | 0.885 | 1.0E-02 |
|
disease | 0.700 | None | 0.953 | 2 | 0 | 1995 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.700 | None | 0.974 | 2 | 0 | 2002 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.700 | None | 0.983 | 2 | 0 | 1991 | 2020 | ||||||||
|
adenylate cyclase 5 | 0.617 | 0.577 | 1.00 |
|
disease | 0.700 | None | 0.947 | 1 | 0 | 2002 | 2019 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
phenotype | 0.700 | None | 0.966 | 1 | 0 | 2002 | 2020 | ||||||||
|
EDAR associated death domain | 0.638 | 0.462 | 3.2E-04 |
|
disease | 0.700 | strong | 1.000 | 1 | 0 | 2002 | 2016 |